Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan/Amlodipine vs Fimasartan in Hypertension
NCT02152306Phase 3Completed
- Sponsor
- Boryung
- Start
- Apr 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fimasartan, amlodipine in essential hypertension, sponsored by Boryung. Started Apr 2014; status: completed.
02
Drugs
fimasartanamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT02152306.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02152306.